重症患者精准抗凝管理方法
抗凝治疗在急症监护中常伴随高发可避免不良事件,重症患者因变量众多、治疗窗窄而管理困难。本文探讨在重症监护期间制定、评估和实施个体化或精准抗凝管理方案的考虑与方法,以辅助临床医生管理这一独特、多变且具挑战性的人群。
要点
- 重症患者抗凝治疗窗窄,需基于持续评估的动态变量制定个体化方案。
- 现有临床试验常仅覆盖部分影响血栓与止血的变量,未反映重症患者动态变化。
- 精准抗凝管理需整合机械支持装置等复杂因素,持续修订管理计划。
核心结论
- 重症患者抗凝管理需采用个体化或精准化方法,整合持续评估和修订的众多变量。
研究设计与样本
- 本文为综述,探讨重症患者抗凝管理的考虑与方法。
主要发现
- 抗凝治疗与高发可避免不良事件相关,尤其在急症监护环境中。
- 重症人群变量众多,许多变量未在试验中探索或常被排除。
- 评估抗凝治疗的试验常仅能覆盖可能影响血栓和止血的小部分变量。
- 重症患者治疗窗相对较小,使安全优化抗凝方案设计困难。
临床怎么用
- 临床医生应为重症患者制定个体化或精准抗凝管理计划,并持续评估和修订。
- 管理计划需纳入重症监护期间持续评估的众多变量及机械支持装置等因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anticoagulant therapy is commonly associated with a high incidence of avoidable adverse events, especially in the acute care setting. This has led to several initiatives by key national health care stakeholders, including specific attention to The Joint Commission's National Patient Safety Goals, to improve anticoagulation management. The subject of special populations has long been identified as challenging by clinicians with the use of anticoagulants. This is driven in part by numerous variables that can contribute to hard outcomes such as bleeding, thrombosis, length of stay, hospital re-admission, morbidity, and mortality. Despite the notable effort to improve the use of anticoagulants with numerous clinical trials, guidelines, guidance statements, and other sources of published evidence, notable difficulties continue to challenge practitioners in managing this class of medications. This is especially the case with very diverse critically ill populations where countless variables exist, many of which were never explored in trials or have historically been frequently excluded. Trials evaluating anticoagulation therapy often can only account for small portions of variables that may affect thrombosis and hemostasis, and study methods often do not reflect the constantly changing dynamic conditions seen in unique critically ill patients. Clinicians providing care to the numerous critically ill populations are faced with conditions that lead to relatively small therapeutic windows, which makes designing safe optimal anticoagulation management plans difficult when dealing with complex patients and mechanical support devices. The approach to crafting a successful management plan for anticoagulant therapy must incorporate the numerous variables that are continuously assessed and revised during the patient's time in the intensive care unit. We explore considerations and approaches when developing, assessing, and implementing an individualized or precision-based management plan that involves the use of anticoagulants in the critically ill. The skills and thought process provided will assist clinicians in managing this unique, variable, and challenging population.
引用
- Dager WE, Trujillo TC, Gilbert BW, et al. Approaches to Precision-based Anticoagulation management in the critically Ill. Pharmacotherapy. 2023. PMID: 37604646. doi:10.1002/phar.2868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。